JP2024529307A5 - - Google Patents
Info
- Publication number
- JP2024529307A5 JP2024529307A5 JP2024500469A JP2024500469A JP2024529307A5 JP 2024529307 A5 JP2024529307 A5 JP 2024529307A5 JP 2024500469 A JP2024500469 A JP 2024500469A JP 2024500469 A JP2024500469 A JP 2024500469A JP 2024529307 A5 JP2024529307 A5 JP 2024529307A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- acid
- conjugate according
- alkyl
- sifa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2109922.1 | 2021-07-09 | ||
| GBGB2109922.1A GB202109922D0 (en) | 2021-07-09 | 2021-07-09 | Radiotracers and therapeutics binding to fibroblast activation protein (fap) |
| PCT/US2022/073544 WO2023283627A1 (en) | 2021-07-09 | 2022-07-08 | Radiotracers and therapeutics binding to fibroblast activation protein (fap) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529307A JP2024529307A (ja) | 2024-08-06 |
| JP2024529307A5 true JP2024529307A5 (enExample) | 2025-06-11 |
Family
ID=77353994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500469A Pending JP2024529307A (ja) | 2021-07-09 | 2022-07-08 | 線維芽細胞活性化タンパク質（ｆａｐ）に結合する放射性トレーサーおよび治療薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240399001A1 (enExample) |
| EP (1) | EP4366786A1 (enExample) |
| JP (1) | JP2024529307A (enExample) |
| KR (1) | KR20240035488A (enExample) |
| CN (1) | CN117836013A (enExample) |
| GB (1) | GB202109922D0 (enExample) |
| WO (1) | WO2023283627A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118804921A (zh) * | 2023-01-17 | 2024-10-18 | 云合智药（苏州）生物科技有限公司 | 缀合物、配体单元及其用途 |
| WO2024227137A1 (en) * | 2023-04-28 | 2024-10-31 | The Board Of Regents Of The University Of Texas System | Structurally-reinforced stable theranostic copper radiopharmaceuticals targeting fibroblast activation protein for cancer diagnosis and therapy |
| AU2024381248A1 (en) * | 2023-11-16 | 2026-06-11 | Praxis Biotech LLC | Conjugates targeting fibroblast activation protein and uses thereof |
| WO2026041109A1 (zh) * | 2024-08-23 | 2026-02-26 | 苏州博锐创合医药有限公司 | 成纤维细胞活化蛋白抑制剂及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7162592B2 (ja) | 2016-12-14 | 2022-10-28 | パーデュー・リサーチ・ファウンデイション | 線維芽細胞活性化タンパク質（ｆａｐ）標的イメージングおよび治療 |
| KR20240027896A (ko) | 2017-07-28 | 2024-03-04 | 테크니쉐 우니베르지테트 뮌헨 | 이중 모드 방사성 트레이서 및 치료법 |
| JP2021500373A (ja) | 2017-10-23 | 2021-01-07 | ザ・ジョンズ・ホプキンス・ユニバーシティ | 線維芽細胞活性化タンパク質α（ＦＡＰ−α）を標的とする撮像剤および放射線療法用薬剤 |
| PH12020551205A1 (en) | 2018-02-06 | 2021-04-19 | Univ Heidelberg | Fap inhibitors |
| CA3128406A1 (en) | 2019-01-30 | 2020-08-06 | Technische Universitat Munchen | Cancer diagnostic imaging agents |
| WO2020157177A1 (en) | 2019-01-30 | 2020-08-06 | Technische Universität München | Psma binding dual mode radiotracer and therapeutic |
| PL3997103T3 (pl) | 2019-07-08 | 2025-03-24 | 3B Pharmaceuticals Gmbh | Związki zawierające ligand białka aktywującego fibroblasty i ich zastosowanie |
| CN118955620A (zh) | 2019-07-08 | 2024-11-15 | 3B制药有限公司 | 包含成纤维细胞活化蛋白配体的化合物及其用途 |
-
2021
- 2021-07-09 GB GBGB2109922.1A patent/GB202109922D0/en not_active Ceased
-
2022
- 2022-07-08 JP JP2024500469A patent/JP2024529307A/ja active Pending
- 2022-07-08 EP EP22777124.3A patent/EP4366786A1/en active Pending
- 2022-07-08 US US18/577,580 patent/US20240399001A1/en active Pending
- 2022-07-08 KR KR1020247002851A patent/KR20240035488A/ko active Pending
- 2022-07-08 WO PCT/US2022/073544 patent/WO2023283627A1/en not_active Ceased
- 2022-07-08 CN CN202280053524.XA patent/CN117836013A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020528461A5 (enExample) | ||
| US12419976B2 (en) | Hybrid tracers for targeted cancer imaging and treatment | |
| JP7449864B2 (ja) | エバンスブルー誘導体の化学結合体ならびに前立腺癌を標的とするための放射線療法および造影剤としてのその使用 | |
| CN111285918B (zh) | 用于psma靶向的成像和放射疗法的金属/放射性金属标记的psma抑制物 | |
| ES2932302T3 (es) | Agentes de contraste diméricos | |
| JP2024514528A5 (enExample) | ||
| JP2024536362A5 (enExample) | ||
| BR112020001785A2 (pt) | radiotraçador e compostos radioterapêuticos bimodais | |
| JP2022509220A5 (ja) | 腫瘍抗原標的化剤、医薬組成物、癌診断薬又は癌治療薬、ｉｎ ｖｉｔｒｏ法、及びその化合物 | |
| AU2020215086A1 (en) | Cancer diagnostic imaging agents | |
| AU2016368542A1 (en) | Contrast agents | |
| US12427207B2 (en) | Pharmaceutical formulations | |
| JP2024529307A (ja) | 線維芽細胞活性化タンパク質（ｆａｐ）に結合する放射性トレーサーおよび治療薬 | |
| JP2018524352A (ja) | Ｈｂｅｄ−ビスホスホネート、その放射性金属コンジュゲート、およびセラノスティック剤としてのそれらの使用 | |
| JP2024510267A5 (enExample) | ||
| JP2024505374A (ja) | デュアルモード放射性トレーサーおよびその療法 | |
| JP2025507966A (ja) | 核医学において用いられるセラノスティクスのための３つ以上の標的ベクターを有する標識前駆体および放射性トレーサー | |
| IL305134A (en) | Dual mode radio and medical tracker | |
| CN121909051A (zh) | 靶向成纤维细胞活化蛋白的组合物及其使用方法 | |
| JP2024517971A5 (enExample) | ||
| EA050309B1 (ru) | Фармацевтические составы | |
| HK1248585A1 (en) | Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents | |
| RU2020126278A (ru) | Ингибитор fap | |
| HK1248585B (en) | Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents | |
| JP2002506050A (ja) | 血清中で高い緩和性を有するマンガンキレート |